Jolien Van Cleemput joined the HCRC group as post-doctoral researcher in March 2020. She graduated as veterinarian and completed her Ph.D. at Ghent University. Her doctorate thesis focused on the pathogenesis of equine herpesviruses in the horse. Next, she studied the molecular mechanisms underlying herpesvirus latency as a postdoc in the Enquist laboratory at Princeton University. Now, she aims to identify novel strategies for the treatment of HIV.
Magdalena Sips is a post-doctoral researcher who joined the HCRC group in November 2016. She received her doctoral training from Ghent University and the Ragon Institute of MGH, MIT and Harvard, where she studied the anti-viral functions of natural killer cells and the role of antibodies in driving protection and control of HIV infection. Her work focused on understanding how potent effector immune responses can be targeted and recruited in mucosal and lymphoid tissues, sites of infection and robust HIV replication, to achieve enhanced immune-mediated control of the virus. At HCRC, she continues exploring the immunological pathways involved in immune-protection of HIV-infection aiming to identify novel therapeutic leads that will help achieve sustained HIV control in chronically infected patients.
Wojtek joined the lab in 2018. His project is focused on directing adaptive immune responses towards HIV cure.